Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01798264 · ClinicalTrials.gov registry record · Phase 1
Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes
A Phase 1 study, sponsored by Intarcia Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 44
- Enrollment target
NCT01798264 is a Phase 1 study that has completed, run by Intarcia Therapeutics. The registered enrollment target is 44 participants.
The verdict
NCT01798264, a Phase 1 study, has completed, sponsored by Intarcia Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 44 participants
- Enrollment target
Study Summary
evaluate the safety and tolerability of ITCA 650 in subjects with type 2 diabetes mellitus.
Interventions
- DRUG ITCA 650 (exenatide in DUROS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01798264
The ClinicalTrials.gov registry entry for NCT01798264 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intarcia Therapeutics, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ITCA 650 (exenatide in DUROS) is the first listed.
NCT01798264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01798264 about?
NCT01798264 is a clinical study titled "Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes". evaluate the safety and tolerability of ITCA 650 in subjects with type 2 diabetes mellitus.
What is the current status of trial NCT01798264?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2009-02. Estimated completion is 2009-05.
What interventions are being tested in trial NCT01798264?
The interventions under investigation include: ITCA 650 (exenatide in DUROS) (DRUG).
Who is sponsoring clinical trial NCT01798264?
This trial is sponsored by Intarcia Therapeutics, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.